Clusterin: A protective mediator for ischemic cardiomyocytes?

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 5 58-5, 2005, Pages

  Krijnen, P A J ^a,b   Cillessen, S A G M ^a   Manoe, R ^c   Muller, A ^a,b   Visser, C A ^a,b   Meijer, C J L M ^a   Musters, R J P ^a,b   Hack, C E ^a,b,c   Aarden, L A ^c   Niessen, H W M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute myocardial infarction; Ischemia; Membrane flip flop

Indexed keywords

CLUSTERIN;

ACUTE HEART INFARCTION; ADULT; AGED; ANIMAL CELL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; RAT; SERUM;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CELLS, CULTURED; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HEART; HUMANS; IMMUNOHISTOCHEMISTRY; MYOBLASTS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; RATS;

EID: 27144545769     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00355.2005     Document Type: Article

References (43)

1. Aronow BJ, Lund SD, Brown TL, Harmony JA, and Witte DP. Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection. Proc Natl Acad Sci USA 90: 725-729, 1993.
2. Bailey RW, Aronow B, Harmony JA, and Griswold MD. Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/ApoJ knock-out mice. Biol Reprod 66: 1042-1053, 2002.
3. Bartl MM, Luckenbach T, Bergner O, Ullrich O, and Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 271: 130-141, 2001.
4. Buttyan R, Olsson CA, Pintar J, Chang C, Bandyk M, Ng PY, and Sawczuk IS. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 9: 3473-3481, 1989.
5. Choi-Miura NH, Sakamoto T, Tobe T, Nakano Y, and Tomita M. The role of HDL consisting of SP-40,40, apo A-I, and lipids in the formation of SMAC of complement. J Biochem (Tokyo) 113: 484-487, 1993.
6. Cotran SC, Kumar V, and Robbins LR. (Editors). The heart. In: Robbins Pathologic Basis of Disease (4th ed.). Philadelphia, PA: Saunders, 1989, p. 605-614.
7. De Silva HV, Stuart WD, Duvic CR, Wetterau JR, Ray MJ, Ferguson DG, Albers HW, Smith WR, and Harmony JA. A 70-kDa apolipoprotein designated ApoJ is a marker for subclasses of human plasma high density lipoproteins. J Biol Chem 265: 13240-13247, 1990.
8. De Silva HV, Stuart WD, Park YB, Mao SJ, Gil CM, Wetterau JR, Busch SJ, and Harmony JA. Purification and characterization of apolipoprotein J. J Biol Chem 265: 14292-14297, 1990.
9. Geske FJ, Lieberman R, Strange R, and Gerschenson LE. Early stages of p53-induced apoptosis are reversible. Cell Death Differ 8: 182-191, 2001.
10. Girton RA, Sundin DP, and Rosenberg ME. Clusterin protects renal tubular epithelial cells from gentamicin-mediated cytotoxicity. Am J Physiol Renal Physiol 282: F703-F709, 2002.
11. Gottlieb RA, Gruol DL, Zhu JY, and Engler RL. Preconditioning rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest 97: 2391-2398, 1996.
12. Hammill AK, Uhr JW, and Scheuermann RH. Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp Cell Res 251: 16-21, 1999.
13. Humphreys DT, Carver JA, Easterbrook-Smith SB, and Wilson MR. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274: 6875-6881, 1999.
14. Iguchi K, Hirano K, Hamatake M, and Ishida R. Phosphatidylserine induces apoptosis in adherent cells. Apoptosis 6: 263-268, 2001.
15. Ishikawa Y, Akasaka Y, Ishii T, Komiyama K, Masuda S, Asuwa N, Choi-Miura NH, and Tomita M. Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler Thromb Vasc Biol 18: 665-672, 1998.
16. Jenne DE and Tschopp J. Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid. Proc Natl Acad Sci USA 86: 7123-7127, 1989.
17. Jones SE and Jomary C. Clusterin. Int J Biochem Cell Biol 34: 427-431, 2002.
18. Kirszbaum L, Bozas SE, and Walker ID. SP-40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges. FEBS Lett 297: 70-76, 1992.
19. Klock G, Storch S, Rickert J, Gutacker C, and Koch-Brandt C. Differential regulation of the clusterin gene by Ha-ras and c-myc oncogenes and during apoptosis. J Cell Physiol 177: 593-605, 1998.
20. Krijnen PA, Ciurana C, Cramer T, Hazes T, Meijer CJ, Visser CA, Niessen HW, and Hack CE. IgM colocalises with complement and C reactive protein in infarcted human myocardium. J Clin Pathol 58: 382-388, 2005.
21. Krijnen PA, Meischl C, Hack CE, Meijer CJ, Visser CA, Roos D, and Niessen HW. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol 56: 194-199, 2003.
22. Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, Verheugt FW, Meijer CJ, and Hack CE. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95: 97-103, 1997.
23. Lakins JN, Poon S, Easterbrook-Smith SB, Carver JA, Tenniswood MP, and Wilson MR. Evidence that clusterin has discrete chaperone and ligand binding sites. Biochemistry 41: 282-291, 2002.
24. Mallory GK, White PD, and Salcedo-Salgar J. The speed of healing of myocardial infarction. Am Heart 718: 647-651, 1939.
25. McDonald JF and Nelsestuen GL. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization. Biochemistry 36: 7464-7473, 1997.
26. McGeer PL, Kawamata T, and Walker DG. Distribution of clusterin in Alzheimer brain tissue. Brain Res 579: 337-341, 1992.
27. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, Florio CJ, Groen PA, Witt SA, Kimball TR, Witte DP, Harmony JA, and Aronow BJ. Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 106: 1105-1113, 2000.
28. Miyata M, Biro S, Kaieda H, Eto H, Orihara K, Kihara T, Obata H, Matsushita N, Matsuyama T, and Tei C. Apolipoprotein J/clusterin is induced in vascular smooth muscle cells after vascular injury. Circulation 104: 1407-1412, 2001.
29. Murphy BF, Kirszbaum L, Walker ID, and d'Apice AJ. SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 81: 1858-1864, 1988.
30. Musters RJ, Probstl-Biegelmann E, van Veen TA, Hoebe KH, Op den Kamp JA, Verkleij AJ, and Post JA. Sarcolemmal phosphatidylethanolamine reorganization during simulated ischaemia and reperfusion: reversibility and ATP dependency. Mol Membr Biol 13: 159-164, 1996.
31. Nijmeijer R, Willemsen M, Meijer CJ, Visser CA, Verheijen RH, Gottlieb RA, Hack CE, and Niessen HW. Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death. Am J Physiol Heart Circ Physiol 285: H2218-H2224, 2003.
32. Partridge SR, Baker MS, Walker MJ, and Wilson MR. Clusterin, a putative complement regulator, binds to the cell surface of Staphylococcus aureus clinical isolates. Infect Immun 64: 4324-4329, 1996.
33. Poon S, Easterbrook-Smith SB, Rybchyn MS, Carver JA, and Wilson MR. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding-competent state. Biochemistry 39: 15953-15960, 2000.
34. Poon S, Treweek TM, Wilson MR, Easterbrook-Smith SB, and Carver JA. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett 513: 259-266, 2002.
35. Silkensen JR, Hirsch AT, Lunzer MM, Chmielewski D, Manivel JC, Muellerleile MR, and Rosenberg ME. Temporal induction of clusterin in the peri-infarct zone after experimental myocardial infarction in the rat. J Lab Clin Med 131: 28-35, 1998.
36. Swertfeger DK, Witte DP, Stuart WD, Rockman HA, and Harmony JA. Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury. Am J Pathol 148: 1971-1983, 1996.
37. Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, and Gonos ES. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol 37: 1175-1187, 2002.
38. Tschopp J, Chonn A, Hertig S, and French LE. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9. J Immunol 151: 2159-2165, 1993.
39. Vakeva A, Laurila P, and Meri S. Co-deposition of clusterin with the complement membrane attack complex in myocardial infarction. Immunology 80: 177-182, 1993.
40. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, Schifferli JA, Tschopp J, and French LE. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112: 290-296, 1999.
41. Vlasblom R, Muller A, Musters RJ, Zuidwijk MJ, Van Hardeveld C, Paulus WJ, and Simonides WS. Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes. Cardiovasc Res 63: 537-544, 2004.
42. Wang D, McMillin JB, Bick R, and Buja LM. Response of the neonatal rat cardiomyocyte in culture to energy depletion: effects of cytokines, nitric oxide, and heat shock proteins. Lab Invest 75: 809-818, 1996.
43. Yamada K, Hori Y, Hanafusa N, Okuda T, Nagano N, Choi-Miura NH, Couser WG, Miyata T, Kurokawa K, Fujita T, and Nangaku M. Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury. Kidney Int 59: 137-146, 2001.